Page last updated: 2024-08-17

lysine and Kidney, Polycystic

lysine has been researched along with Kidney, Polycystic in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Agborbesong, E; Li, LX; Li, X; Zhang, L; Zhang, X; Zhou, JX1
Aguilar, A1
Cheng, SH; Fieles, W; Geske, R; Hong, H; Hu, E; Isidro-Llobet, A; Jucker, BM; Klein, JL; Lee, D; Lenhard, SC; McAlexander, A; Nadin, A; Rambo, M; Skedzielewski, T; Trinh, H; Virtue, A1
Chu, H; Felten, AE; Leamon, CP; Lu, YJ; Nelson, M; Parker, N; Reddy, JA; Shillingford, JM; Vaughn, JF; Vlahov, IR; Wang, EZ; Westrick, E; Xu, LC1
Blazícek, P; Dzúrik, R; Gazdíková, K; Heidland, A; Schinzel, R; Sebeková, K; Spustová, V; Syrová, D1

Other Studies

5 other study(ies) available for lysine and Kidney, Polycystic

ArticleYear
Cross talk between lysine methyltransferase Smyd2 and TGF-β-Smad3 signaling promotes renal fibrosis in autosomal dominant polycystic kidney disease.
    American journal of physiology. Renal physiology, 2022, 08-01, Volume: 323, Issue:2

    Topics: Animals; Cysts; Fibrosis; Histones; Kidney; Lysine; Methyltransferases; Mice; NIH 3T3 Cells; Polycystic Kidney Diseases; Polycystic Kidney, Autosomal Dominant; Rats; Smad3 Protein; Transforming Growth Factor beta

2022
Polycystic kidney disease: SMYD2 is a novel epigenetic regulator of cyst growth.
    Nature reviews. Nephrology, 2017, Volume: 13, Issue:9

    Topics: Cysts; Epigenesis, Genetic; Histone-Lysine N-Methyltransferase; Humans; Lysine; Methyltransferases; Polycystic Kidney Diseases; Polycystic Kidney, Autosomal Dominant

2017
In Vivo Imaging of Small Molecular Weight Peptides for Targeted Renal Drug Delivery: A Study in Normal and Polycystic Kidney Diseased Mice.
    The Journal of pharmacology and experimental therapeutics, 2019, Volume: 370, Issue:3

    Topics: Animals; Aquaporin 1; Coloring Agents; Drug Delivery Systems; Drug Design; Epithelium; Glutamic Acid; Humans; Kidney; Kidney Cortex; Kidney Neoplasms; Kidney Tubules, Proximal; Low Density Lipoprotein Receptor-Related Protein-2; Lysine; Magnetic Resonance Imaging; Mice; Peptides; Polycystic Kidney Diseases; Tissue Distribution

2019
Detecting Functional and Accessible Folate Receptor Expression in Cancer and Polycystic Kidneys.
    Molecular pharmaceutics, 2019, 09-03, Volume: 16, Issue:9

    Topics: A549 Cells; Animals; Doxycycline; Fluorescein-5-isothiocyanate; Folate Receptor 1; Folic Acid; HeLa Cells; Humans; Lysine; Mice; Mice, Inbred BALB C; Mice, Nude; Mice, Transgenic; Molecular Targeted Therapy; Neoplasms; Oligopeptides; Polycystic Kidney Diseases; Protein Kinase C; Tissue Distribution; Trityl Compounds; Xenograft Model Antitumor Assays

2019
Effects of ramipril in nondiabetic nephropathy: improved parameters of oxidatives stress and potential modulation of advanced glycation end products.
    Journal of human hypertension, 2003, Volume: 17, Issue:4

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Blood Glucose; Blood Pressure; Creatinine; Cystatin C; Cystatins; Diabetic Nephropathies; Female; Glomerulonephritis; Glycation End Products, Advanced; Homocysteine; Humans; Lipofuscin; Lysine; Male; Malondialdehyde; Middle Aged; Nephritis, Interstitial; Oxidative Stress; Polycystic Kidney Diseases; Ramipril; Severity of Illness Index; Statistics as Topic; Treatment Outcome

2003